Form 8-K - Current report:
SEC Accession No. 0001437749-25-021343
Filing Date
2025-06-26
Accepted
2025-06-26 16:07:21
Documents
13
Period of Report
2025-06-26
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctnm20250616c_8k.htm   iXBRL 8-K 30508
  Complete submission text file 0001437749-25-021343.txt   164858

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctnm-20250626.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctnm-20250626_def.xml EX-101.DEF 11804
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctnm-20250626_lab.xml EX-101.LAB 15848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctnm-20250626_pre.xml EX-101.PRE 12019
15 EXTRACTED XBRL INSTANCE DOCUMENT ctnm20250616c_8k_htm.xml XML 2965
Mailing Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 3565 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Filer) CIK: 0001855175 (see all company filings)

EIN.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42001 | Film No.: 251080420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)